GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...
A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and French biotech firm Valneva SE, have expanded th...
Mélanie Joly, Canada’s Minister of Foreign Affairs, visited the International Vaccine Institute’s (IV...
Indian Immunologicals Ltd (IIL), led by its Chairman Dr Meenesh Shah and Managing Director Dr K. Anand Kumar, has donate...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
Merck, a leading science and technology company, has announced that its life science business sector has entered a...
South Korea-based International Vaccine Institute (IVI) has signed a memorandum of understanding (MoU) with the Catholic...
Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exp...
The International Vaccine Institute (IVI) has exchanged a trilateral Memorandum of Understanding (MoU) with the Korea Ad...
Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secure...